Rheumatoid Arthritis Clinical Trials in New York

Showing 881-900 of 3,596 trials

OCS DCD Heart + CAP Continued Follow-Up

NCT05741723

The objective of this post-approval study is to evaluate long-term outcomes of patients enrolled in the OCS DCD Heart and OCS DCD Heart CAP studies.

Heart Transplant

TransMedics276 participantsStarted Nov 2019

La Jolla, California, United States • Palo Alto, California, United States • New Haven, Connecticut, United States +17 more locations

COMPLETEDPhase 2< 1 mile

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

NCT03499808

This phase II trial studies how well isatuximab works in treating patients with primary amyloidosis that has come back or does not respond to treatment. Monoclonal antibodies, such as isatuximab, may interfere with the ability of cancer cells to grow and spread.

Amorphous, Eosinophilic, and Acellular DepositConstipationDiarrhea+10 more

SWOG Cancer Research Network43 participantsStarted Jun 2018

Anchorage, Alaska, United States • Anchorage, Alaska, United States • Anchorage, Alaska, United States +342 more locations

OCS DCD Heart + CAP Continued Follow-Up

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

Rheumatoid Arthritis Trials in Other Cities

Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma

A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors

The EBC Recovery Study

Effect of Treatment Modality on Psychosocial Functioning of Survivors of Unilateral Retinoblastoma

Expanded Access Program for Revumenib

Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention

A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Cardiovascular Function and Response to Stimulation Within the First Year After Spinal Cord Injury

GV1001 Subcutaneous(SC) for the Treatment of Mild to Moderate Alzheimer's Disease (AD)

A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine

A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab

PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children

Cognitive Behavioural Therapy to Optimize Post-Operative Recovery Trial

Efficacy and Safety of Tolebrutinib (SAR442168) Tablets in Adult Participants With Generalized Myasthenia Gravis

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

Study of an Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Long Term Follow-up of Integra® Cadence™ Total Ankle System in Primary Ankle Joint Replacement

BR101801 in Adult Patients With Advanced Hematologic Malignancies(Phase I)

Other Conditions in New York